Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Vanover, K. E.
  • Weiner, D. M.
  • Makhay, M.
  • Veinbergs, I.
  • Gardell, L. R.
  • Lameh, J.
  • Del Tredici, Andria Lee
  • Piu, F.
  • Schiffer, H. H.
  • Ott, T. R.
  • Burstein, E. S.
  • Uldam, A. K.
  • Thygesen, M. B.
  • Schlienger, N.
  • Andersson, C. M.
  • Son, T. Y.
  • Harvey, S. C.
  • Powell, S. B.
  • Geyer, M. A.
  • Tolf, B. R.
  • Brann, M. R.
  • Davis, R. E.

publication date

  • May 2006

journal

  • Journal of Pharmacology and Experimental Therapeutics  Journal

subject areas

  • Animals
  • Behavior, Animal
  • Biological Availability
  • Cloning, Molecular
  • Humans
  • Male
  • Mice
  • NIH 3T3 Cells
  • Piperidines
  • Radioligand Assay
  • Rats
  • Rats, Sprague-Dawley
  • Serotonin 5-HT2 Receptor Antagonists
  • Serotonin Antagonists
  • Urea
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0022-3565

Digital Object Identifier (DOI)

  • 10.1124/jpet.105.097006

PubMed ID

  • 16469866
scroll to property group menus

Additional Document Info

start page

  • 910

end page

  • 918

volume

  • 317

issue

  • 2

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support